Literature DB >> 12937105

Severe and unrecognised: pertussis in UK infants.

N S Crowcroft1, R Booy, T Harrison, L Spicer, J Britto, Q Mok, P Heath, I Murdoch, M Zambon, R George, E Miller.   

Abstract

AIMS: To diagnose pertussis using culture, polymerase chain reaction, and serology, in children admitted to intensive care units (PICUs) and some paediatric wards in London, and in their household contacts to determine the source of infection.
METHODS: Infants <5 months old admitted to London PICUs between 1998 and 2000 with respiratory failure, apnoea and/or bradycardia, or acute life threatening episodes (ALTE), and children <15 years admitted to paediatric wards at St Mary's and St George's Hospitals between 1999 and 2000 with lower respiratory tract infection, apnoea, or ALTE were studied.
RESULTS: Sixty seven per cent of eligible children (142/212) were recruited; 23% (33/142) had pertussis, 19.8% (25/126) on the PICU and 50% (8/16) on wards. Two died. Only 4% (6/142) were culture positive. Pertussis was clinically suspected on admission in 28% of infants (7/25) on the PICU and 75% (6/8) on the wards. Infants on PICU with pertussis coughed for longer, had apnoeas and whooped more often, and a higher lymphocyte count than infants without pertussis. Pertussis and respiratory syncytial virus (RSV) co-infection was frequent (11/33, 33%). Pertussis was confirmed in 22/33 (67%) of those who were first to become ill in the family. For 14/33 children the source of infection was a parent; for 9/33 the source of pertussis was an older fully vaccinated child in the household.
CONCLUSIONS: Severe pertussis is under diagnosed. An RSV diagnosis does not exclude pertussis. Future changes to the UK vaccination programme should aim to reduce pertussis transmission to young infants by their parents and older siblings.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937105      PMCID: PMC1719623          DOI: 10.1136/adc.88.9.802

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  Bordetella pertussis surveillance in England and Wales: 1995-7.

Authors:  P G Van Buynder; D Owen; J E Vurdien; N J Andrews; R C Matthews; E Miller
Journal:  Epidemiol Infect       Date:  1999-12       Impact factor: 2.451

2.  Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.

Authors:  H E de Melker; F G Versteegh; M A Conyn-Van Spaendonck; L H Elvers; G A Berbers; A van Der Zee; J F Schellekens
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales.

Authors:  W John Edmunds; Marc Brisson; Alessia Melegaro; Nigel J Gay
Journal:  Vaccine       Date:  2002-01-31       Impact factor: 3.641

Review 4.  Pertussis: an old disease that is still with us.

Authors:  U Heininger
Journal:  Curr Opin Infect Dis       Date:  2001-06       Impact factor: 4.915

5.  Pertussis is increasing in unimmunized infants: is a change in policy needed?

Authors:  S Ranganathan; R Tasker; R Booy; P Habibi; S Nadel; J Britto
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

6.  Whooping cough--a continuing problem.

Authors:  N S Crowcroft; Joseph Britto
Journal:  BMJ       Date:  2002-06-29

7.  Specific identification of Bordetella pertussis by the polymerase chain reaction.

Authors:  S Houard; C Hackel; A Herzog; A Bollen
Journal:  Res Microbiol       Date:  1989-09       Impact factor: 3.992

8.  Is there a carrier state in pertussis?

Authors:  J W Bass
Journal:  Lancet       Date:  1987-01-10       Impact factor: 79.321

9.  Influence of vaccination coverage on pertussis transmission in France.

Authors:  E Grimprel; S Baron; D Lévy-Bruhl; J M Garnier; E N'jamkepo; N Guiso; P Bégué
Journal:  Lancet       Date:  1999-11-13       Impact factor: 79.321

10.  Deaths from pertussis are underestimated in England.

Authors:  N S Crowcroft; N Andrews; C Rooney; M Brisson; E Miller
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

View more
  40 in total

1.  Seroprevalence of pertussis among Danish patients with cough of unknown etiology.

Authors:  Tine Dalby; Zitta B Harboe; Karen Angeliki Krogfelt
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  External quality assessment for molecular detection of Bordetella pertussis in European laboratories.

Authors:  G Muyldermans; O Soetens; M Antoine; S Bruisten; B Vincart; F Doucet-Populaire; N K Fry; P Olcén; J M Scheftel; J M Senterre; A van der Zee; M Riffelmann; D Piérard; S Lauwers
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

3.  Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.

Authors:  Girish S Kirimanjeswara; Luis M Agosto; Mary J Kennett; Ottar N Bjornstad; Eric T Harvill
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

Review 4.  Vaccination greatly reduces disease, disability, death and inequity worldwide.

Authors:  F E Andre; R Booy; H L Bock; J Clemens; S K Datta; T J John; B W Lee; S Lolekha; H Peltola; T A Ruff; M Santosham; H J Schmitt
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

Review 5.  Pertussis vaccination for health care workers.

Authors:  Thomas J Sandora; Courtney A Gidengil; Grace M Lee
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

6.  Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type.

Authors:  David J Litt; Shona E Neal; Norman K Fry
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

Review 7.  [Vaccination in adults].

Authors:  D M Kieninger-Baum; F Zepp
Journal:  Internist (Berl)       Date:  2011-03       Impact factor: 0.743

8.  Different effects of whole-cell and acellular vaccines on Bordetella transmission.

Authors:  William E Smallridge; Olivier Y Rolin; Nathan T Jacobs; Eric T Harvill
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

9.  Parents as source of pertussis transmission in hospitalized young infants.

Authors:  Giorgio Fedele; Maria Carollo; Raffaella Palazzo; Paola Stefanelli; Elisabetta Pandolfi; Francesco Gesualdo; Alberto Eugenio Tozzi; Rita Carsetti; Alberto Villani; Ambra Nicolai; Fabio Midulla; Clara Maria Ausiello
Journal:  Infection       Date:  2016-09-10       Impact factor: 3.553

10.  Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Christopher D Paddock; Tara F Jones; Shandra R Day; James Bowden; Melinda D Poulter; Gina M Donato; Tod J Merkel; Erik L Hewlett
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.